Raad Mohamad, Oranefo Justice, Yogasundaram Haran, Gurin Michael I, Zado Erica, Walsh Michelle, Markman Timothy, Guandalini Gustavo, Hyman Matthew C, Schaller Robert, Kumareswaran Ramanan, Supple Gregory, Deo Rajat, Nazarian Saman, Riley Michael, Lin David, Garcia Fermin, Frankel David S, Callans David, Epstein Andrew E, Marchlinski Francis E, Dixit Sanjay
Electrophysiology Section, Division of Cardiovascular Medicine, Perelman School of Medicine at University of Pennsylvania, Philadelphia, Pennsylvania, USA.
J Cardiovasc Electrophysiol. 2025 Aug;36(8):1966-1972. doi: 10.1111/jce.16764. Epub 2025 Jun 23.
Long-standing persistent atrial fibrillation (LSPAF) is associated with adverse atrial structural and electrical remodeling, limiting the success of catheter ablation (CA).
To determine whether temporary restoration of sinus rhythm (TRSR) can improve the single procedure efficacy of CA in patients with LSPAF.
Patients with LSPAF undergoing their first CA between 2016 and 2022 were included. TRSR was attempted using cardioversion, with or without antiarrhythmic drugs (AAD), no later than 6 months before CA. The ablation strategy included pulmonary vein isolation (PVI), non-PV trigger ablation, and linear lesions for organized atrial tachyarrhythmias (OAT). The primary study outcome was freedom from atrial arrhythmias (AA: AF and/or OAT) on/off AAD at 12 months, and the secondary outcome was freedom from AA off AAD at 12 months.
One hundred eighty patients (median age 66 years, 24% female) were included. TRSR was attempted in 67 (37%) patients, and 17 (25%) of these presented in SR at the time of CA. Patients undergoing TRSR had more comorbidities (CHADS-VASc score 3.1 vs. 2.7, p = 0.012) than those who did not. The primary and secondary outcomes were significantly better in the TRSR than the no TRSR group: AA-free survival (73% vs. 51%, p = 0.004) and AA-free survival off AAD (69% vs. 45%, p = 0.002). The primary outcome was better in the TRSR group, whether the presenting rhythm at CA was SR or AF (75% and 72%, respectively).
TRSR within 6 months of CA was associated with improved arrhythmia-free survival in LSPAF patients undergoing CA regardless of the presenting rhythm at ablation.
长期持续性心房颤动(LSPAF)与不良的心房结构和电重构相关,限制了导管消融(CA)的成功率。
确定窦性心律临时恢复(TRSR)是否能提高LSPAF患者CA单次手术的疗效。
纳入2016年至2022年间首次接受CA的LSPAF患者。在CA前不晚于6个月尝试使用电复律(无论是否使用抗心律失常药物(AAD))进行TRSR。消融策略包括肺静脉隔离(PVI)、非肺静脉触发灶消融以及针对有组织的房性快速性心律失常(OAT)的线性消融。主要研究结局是12个月时停用/使用AAD情况下无房性心律失常(AA:房颤和/或OAT),次要结局是12个月时停用AAD情况下无AA。
纳入180例患者(中位年龄66岁,24%为女性)。67例(37%)患者尝试进行TRSR,其中17例(25%)在CA时呈现为窦性心律。进行TRSR的患者比未进行TRSR的患者合并症更多(CHADS-VASc评分3.1比2.7,p = 0.012)。TRSR组的主要和次要结局显著优于未进行TRSR组:无AA生存率(73%比51%,p = 0.004)以及停用AAD时的无AA生存率(69%比45%,p = 0.002)。无论CA时的呈现心律是窦性心律还是房颤,TRSR组的主要结局均更好(分别为75%和72%)。
在CA前6个月内进行TRSR与接受CA的LSPAF患者无心律失常生存率的提高相关,无论消融时的呈现心律如何。